Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant - PowerPoint PPT Presentation

Mar 16, 2024 •308 likes •499 views

Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant Oncologist MRCP(UK), MRCP(Ireland),FRCR, ESMO, MSc(Healthcare leadership) Clinical Lead, Oncology, Spire Specialist Centre Consultant Clinical Oncologist, Mid Essex Hospital Services

Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant Oncologist MRCP(UK), MRCP(Ireland),FRCR, ESMO, MSc(Healthcare leadership) Clinical Lead, Oncology, Spire Specialist Centre Consultant Clinical Oncologist, Mid Essex Hospital Services NHS Trust. Honorary Consultant Oncologist, Colchester Hospital University NHS Foundation Trust
Current Landscape of Cancer 3
Can they wait? Waiting targets • For initial diagnosis? • For treatment? • For suspected recurrence or metastases? • For treatment related complications?
Rising burden of cancer • Cancer services cost 6.7 billion /year 2012- 13 (National audit office) • Projected cost for 2020 - 13 billion • Early diagnosis may allow at least 11000 patients per year surviving cancer by 2020 BUPA Cancer Care 2020 5
Why can not they wait? • Performance status and quality of life • Exponential growth ( cancer recovery secrets) • Survival outcome • Better treatment options
Pertuzumab/Herceptin/Doc etaxel
Immune related Adverse Events Endocrine- Neurological- Thyroid, neuropathy, Gastro- Colitis Adrenal, Myaesthenia, pituitary Guillain Barre Renal-Nephritis, Skin- rash, Pulmonary- acute renal Steven Pneumonitis failure Johnsons, TEN Cardiology - Myocarditis, Hypersensitivity Hepatitis pericarditis
PET/CT Fusion CT based GTV PET/CT based GTV
Tumour markers • CEA • PSA • AFP, HCG,LDH • CA19.9 • CA15.3
6 basic human psychological needs* • Love / Connection • Value / significance • Clarity/ certainty • Variety • Growth • Contribution *Ref- Executive Decisions Dr. Sunil Skaria
Thank you 18

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Counseling Patients Experiencing Financial Toxicity Dan Sherman, MA. LPC Cancer patients

Counseling Patients Experiencing Financial Toxicity Dan Sherman, MA. LPC Cancer patients demonstrate more anxiety over the cost of treatment than over dying from their disease . Oncology Times, August 2009 42% of insured cancer patients

332 views • 30 slides

Quick review of patients are .. pharmacokinetic-based The concentration-effect (i.e.,

Awareness of drug interactions increasing in patients with cancer Drug Interactions in Stem Prevalence in HSCT patients Cell Transplantation unknown 4.5-58% in cancer patients Numerous electronic databases exist with variable

249 views • 8 slides

Patients in the Genomic Era Marc Lippman, MD The Sylvester Comprehensive Cancer Center at the

Selecting Therapy for Breast Cancer Patients in the Genomic Era Marc Lippman, MD The Sylvester Comprehensive Cancer Center at the University of Miami PERSONALIZED MEDICINE FOR BREAST CANCER PATIENTS A WORKING DEFINITION: SUFFICIENT

764 views • 62 slides

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse Coordinators Caitlin Broderick Lung Cancer an overview Most recent stats from WA Cancer Registry (2013) Incidence 1000 cases, Death 788

330 views • 15 slides

60% 78% H&N 705,781 18M 60% Prostate 1,276,106 61% Rectum 704,376 new patients per

RECEIVING RTx NUMBER OF PATIENTS 83% Breast cancer 2,088,849 76% Lung cancer 2,093,876 60% 78% H&N 705,781 18M 60% Prostate 1,276,106 61% Rectum 704,376 new patients per year 57% Pancreas 458,918 92% CNS 296,851 Inadequate

730 views • 47 slides

Breast Cancer Path of Support Milestones for Empowering and Assisting Breast Cancer Patients

Breast Cancer Path of Support Milestones for Empowering and Assisting Breast Cancer Patients I lana Kadmon (RN, PhD) The Israel Cancer Association 1 Promoting the fight against breast cancer I CAs Aim: Reducing breast cancer

555 views • 23 slides

Breast Cancer Molecular Subtypes Patients and Tumors Between Patients: subtypes How to use

Breast Cancer Heterogeneity Breast Cancer Molecular Subtypes Patients and Tumors Between Patients: subtypes How to use Molecular Diagnostic Tests in Breast Diseases Laura J. van t Veer Within Tumors: subclones University of California, San

356 views • 8 slides

WORKING WITH YOUNG CANCER PATIENTS FROM EXPERIENCE TO ACTIVITY WHAT DOES A CHILD WITH CANCER

WORKING WITH YOUNG CANCER PATIENTS FROM EXPERIENCE TO ACTIVITY WHAT DOES A CHILD WITH CANCER NEED (I) Non-medical support Constant care form specialists Rehabilitation and parents Complex Education and CHILD treatment development

340 views • 14 slides

Independent Cancer Patients Voice Access and Consent in Biobanking Workshop Newcastle 10 th

Independent Cancer Patients Voice Access and Consent in Biobanking Workshop Newcastle 10 th October 2012 Response to the NCRI Template for Access Christine Allmark Independent Cancer Patients Voice Independent Cancer Patients Voice

299 views • 8 slides

Update on Adjuvant and Salvage Options for Patients with Kidney Cancer A Ari Hakimi, MD

Update on Adjuvant and Salvage Options for Patients with Kidney Cancer A Ari Hakimi, MD Assistant Attending, Dept of Surgery, Urology Sidney Kimmel Center for Prostate and Urologic Cancer Memorial Sloan Kettering Cancer Center, New York

480 views • 30 slides

IAEA Support for Radiotherapy Services for Patients with Cervical Cancer Kirsten Hopkins Applied

Gynecologic Cancer InterGroup Cervix Cancer Research Network IAEA Support for Radiotherapy Services for Patients with Cervical Cancer Kirsten Hopkins Applied Radiation Biology and Radiotherapy Section Division of Human Health Cervix Cancer

358 views • 17 slides

Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided

Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided Brachytherapy Faleh Al-shameri (falshame@gmu.edu) Jee Vang (jvang@gmu.edu) Interface,2004 Background on Prostate Cancer Most common cancer

451 views • 15 slides

Engaging the corporate sector to support cancer patients - The Australian

Engaging the corporate sector to support cancer patients - The Australian experience " Paula Vallentine Manager, Direct Cancer Services, CISS Cancer Council NSW Where we are situated " Where we are situated "

491 views • 16 slides

Small Cell Lung Cancer, or Head and Neck cancer patients receiving eftilagimod alpha (a soluble

Poster Board: 18 LB-394 Initial results from a Phase II study (TACTI-002) in Non- Small Cell Lung Cancer, or Head and Neck cancer patients receiving eftilagimod alpha (a soluble LAG-3 protein) and pembrolizumab 27 th April 2020 Presenting

264 views • 7 slides

Epithelial Ovarian Cancer (EOC) 5 th commonest cause of female cancer death 1300 new cases

Epithelial Ovarian Cancer (EOC) 5 th commonest cause of female cancer death 1300 new cases in Australia per year Patients with extensive disease can have surgery Most patients disease returns within 2-5 years Desperate need

195 views • 7 slides

NAC FOR cN1 BREAST CANCER PATIENTS - NO Stephen R. Grobmyer, MD, FACS Professor of Surgery Zapis

TARGETED AXILLARY DISSECTION FOLLOWING NAC FOR cN1 BREAST CANCER PATIENTS - NO Stephen R. Grobmyer, MD, FACS Professor of Surgery Zapis Endowed Chair for Breast Cancer Research Co-Leader, Breast Cancer Program Cleveland Clinic Cleveland, Ohio

392 views • 17 slides

Barry-Eaton District Health Department Time of Sale or Transfer Program (TOST) The First Three

Barry-Eaton District Health Department Time of Sale or Transfer Program (TOST) The First Three Years 2007-2010 Caring for the Community Since the 1930s Overview What is TOST How it works Outcome of TOST Pictures ---worth

758 views • 46 slides

Barry Barry Eaton District Health y Eaton District Health Department Department Time of Sale

Barry Barry Eaton District Health y Eaton District Health Department Department Time of Sale or Transfer Program Ti Time of Sale or Transfer Program Ti f S l f S l T T f f P P ( (TOST) ( (TOST) ) ) The First Three Years The

961 views • 70 slides

www.R .RareAd areAdvo voca cates.or tes.org DC Office with workstation & meeting space

Designed to be a clearinghouse & advocacy center for all Rare Disease Legislation Provides resources & tools for individuals & organizations All events & resources are free & open to the entire Rare Disease

285 views • 12 slides

Gran Forsberg, CEO May 2020 Safe Harbour Sta tatement Statements in the Investor

We want to save patients with severe cancer and autoimmune diseases Clinical investigations with our lead antibody CAN04 to our proprietary target Gran Forsberg, CEO May 2020 Safe Harbour Sta tatement Statements in the Investor Presentation,

145 views • 13 slides

The Role of CMR in Cardio-Oncology Dr Mark Westwood Consultant Cardiologist Barts Heart Centre

The Role of CMR in Cardio-Oncology Dr Mark Westwood Consultant Cardiologist Barts Heart Centre CMR + Cardio-Oncology ESC position paper 9 Pillars What can CMR offer Future directions Breadth of Scope Position Paper 2016

680 views • 52 slides

Cardiac PET - SPECT Registration Interdisciplinary Project Final Presentation May 29, 2009 Brian

Cardiac PET - SPECT Registration Interdisciplinary Project Final Presentation May 29, 2009 Brian Jensen Computer Aided Medical Procedures (CAMP), Technische Universitt Mnchen, Germany Department of Nuclear Medicine University Hospital

514 views • 25 slides

WESTPAC workshop on the development of a research strategy for Harmful Algal Blooms Toward the

WESTPAC workshop on the development of a research strategy for Harmful Algal Blooms Toward the future development of HAB science in the Western Pacific What we know, and what we do not know on HABs National Research Institute of

855 views • 84 slides

Futhark A data-parallel pure functional programming language compiling to GPU Troels Henriksen

Futhark A data-parallel pure functional programming language compiling to GPU Troels Henriksen (athas@sigkill.dk) Computer Science University of Copenhagen 31. May 2016 ME PhD student at the Department of Computer Science at the University

1.04k views • 81 slides